Anogenital cancers testing in Cosenza

Find health labs to test for Anogenital cancers in Cosenza and compare all offers by prices and services.

Tests that cover Anogenital cancers

HPV Test
Pap Smear by Laboratorio Lifebrain

Viale Giovanni e Francesca Falcone, 404/A 87100 Cosenza (CS)

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Ugo Cavalcanti- 7-11 87100 Cosenza (CS)

Unverified

See Details

Pap Test by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

test HPV cavo orale autoprelievo by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

Pap Smear by Laboratorio Lifebrain

Via Giacomo Puccini, 10 87036 Rende (CS)

4.8 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Ina Casa, 7 87040 Luzzi (CS)

10.7 km

Unverified

See Details

Pap Smear by Synlab

Via 20 Settembre, 91, 88046 Lamezia Terme CZ, Italia

22.2 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

via Rialto 3 88816 Crotone (KR)

40.5 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Amedo Avogadro SNC 88900 Crotone (KT)

48.8 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via A. Moro, 17 88811 Cirò Marina (KR)

47 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Roma, 111 88900 Crotone (KR)

48.8 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Dante Alighieri 39, Palmi, RC, Italia 89015 Palmi (RC)

68.3 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Giovanni Bovi, 6, Palmi, RC, Italia 89015 Palmi (RC)

68.3 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Viale Jonio, snc 74025 Marina di Ginosa (TA)

92.6 km

Unverified

See Details

Anogenital cancers - symptoms and how to test

Human papillomavirus (HPV) infection is linked to anogenital malignancies, namely to the alpha genus of mucosal HPV types 16 and 1810,11. There is some evidence that beta-genus HPVs contribute to cutaneous SCC, although it is inconclusive. High-risk HPVs account for 3% of all female malignancies and 2% of all male cancers in the United States. The Centers for Disease Control and Prevention report that each year there are around 45,000 new instances of cancer in areas of the body where HPV is often present. HPV is predicted to cause approximately 36,000 of these (CDC). The HPV test screens for the presence of high-risk HPV strains that are associated with an increased risk of developing cervix precancers and malignancies.